Functionally, MDSCs hamper anti-tumor immunity by impairing T cell proliferation, IFNγ responses, and NK cell function (20, 21, 23–29) while facilitating the expansion of regulatory T cells (Tregs) (9, 30, 31), thus contributing to tumor evasion. The gene discussed is IFNG; the disease is neoplasm.